Patents by Inventor Richard C. Austin

Richard C. Austin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7524826
    Abstract: The present invention provides methods for preventing the generation of active thrombin on the surface of cells. The present methods are based upon the surprising discovery that expression or activation of an ER resident chaperone protein in a cell inhibits the generation of thrombin on the surface of the cell. Accordingly, expressing or activating an ER resident chaperone protein can be used to treat or prevent any of a number of thrombotic diseases.
    Type: Grant
    Filed: April 12, 2001
    Date of Patent: April 28, 2009
    Assignee: McMaster University and Hamilton Health Sciences Corporation
    Inventors: Richard C. Austin, Anthony K. C. Chan, Leslie Roy Berry
  • Publication number: 20020039791
    Abstract: The present invention provides methods for preventing the generation of active thrombin on the surface of cells. The present methods are based upon the surprising discovery that expression or activation of an ER resident chaperone protein in a cell inhibits the generation of thrombin on the surface of the cell. Accordingly, expressing or activating an ER resident chaperone protein can be used to treat or prevent any of a number of thrombotic diseases.
    Type: Application
    Filed: April 12, 2001
    Publication date: April 4, 2002
    Inventors: Richard C. Austin, Anthony K.C. Chan, Leslie Roy Berry
  • Patent number: 6132965
    Abstract: A method for diagnosing hyperhomocysteinemia by molecular genetic means is disclosed.
    Type: Grant
    Filed: January 30, 1998
    Date of Patent: October 17, 2000
    Assignee: Hamilton Civic Hospitals Research Development Inc.
    Inventors: Richard C. Austin, Jack Hirsh, Jeffrey I. Weitz
  • Patent number: 5817461
    Abstract: A method for diagnosing hyperhomocysteinemia by molecular genetic means is disclosed.
    Type: Grant
    Filed: January 3, 1996
    Date of Patent: October 6, 1998
    Assignee: Hamilton Civic Hospitals Research Development Inc.
    Inventors: Richard C. Austin, Jack Hirsh, Jeffrey I. Weitz